glp 1 vs sglt2 diabetes GLP-1 receptor agonists vs. SGLT-2 inhibitors: the gap seems to be leveling off | Cardiovascular Diabetology GLP1 Receptor Agonists vs SGLT2-I

Landmark cardiovascular outcome trials (CVOTs) provided the first consistent signals of renal benefit with GLP-1RAs, largely driven by exploratory composite kidney endpoints and reductions in new or worsening albuminuria (e.g., LEADER, REWIND, SUSTAIN-6, EXSCEL, and ELIXA

I know I would If you are an employer trying to compete for younger talent right now, that number belongs in your benefits strategy conversation immediately

Function and mechanisms of enteroendocrine cells and gut hormones in metabolism

Shih, C

The withdrawal pattern typically involves gradual return of appetite over 2 to 4 weeks, followed by weight regain over the subsequent months

But lets go back to square 1, what are GLP-1 drugs